scispace - formally typeset
Journal ArticleDOI

Pharmacologic overview of Withania somnifera, the Indian Ginseng

Reads0
Chats0
TLDR
Withania somnifera is a potential drug candidate to treat various clinical conditions, particularly related to the nervous system, and the mechanisms of action and potential therapeutic applications of the plant and its active constituents are discussed.
Abstract
Withania somnifera, also called 'Indian ginseng', is an important medicinal plant of the Indian subcontinent. It is widely used, singly or in combination, with other herbs against many ailments in Indian Systems of Medicine since time immemorial. Withania somnifera contains a spectrum of diverse phytochemicals enabling it to have a broad range of biological implications. In preclinical studies, it has shown anti-microbial, anti-inflammatory, anti-tumor, anti-stress, neuroprotective, cardioprotective, and anti-diabetic properties. Additionally, it has demonstrated the ability to reduce reactive oxygen species, modulate mitochondrial function, regulate apoptosis, and reduce inflammation and enhance endothelial function. In view of these pharmacologic properties, W. somnifera is a potential drug candidate to treat various clinical conditions, particularly related to the nervous system. In this review, we summarize the pharmacologic characteristics and discuss the mechanisms of action and potential therapeutic applications of the plant and its active constituents.

read more

Citations
More filters
Journal ArticleDOI

Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions

TL;DR: An attempt has been made to elucidate the molecular mode of action of various plant extracts, phytochemicals and traditional herbal formulations investigated against AD as reported in various preclinical and clinical tests.
Journal ArticleDOI

Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products

TL;DR: This study used chemoproteomic platforms to discover that the anti-cancer natural product withaferin A targets C377 on the regulatory subunit PPP2R1A of the tumor-suppressor protein phosphatase 2A (PP2A) complex leading to activation of PP2A activity, inactivation of AKT, and impaired breast cancer cell proliferation.
Journal ArticleDOI

Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach.

TL;DR: Based on proven therapeutic, that is, immunomodulatory, antioxidant and anti-inflammatory roles and plausible potential against n-CoV-2 proteins, Indian ginseng could be one of the alternatives as an antiviral agent in the treatment of COVID 19.
Journal ArticleDOI

Chromatographic And Spectroscopic Characterization Of The Consciousness Energy Healing Treated Withania Somnifera (Ashwagandha) Root Extract

TL;DR: Energy of Consciousness Healing Treatment could be advantageous for altering the concentration of the phytoconstituents in the ashwagandha root extract by modifying their intrinsic physicochemical properties, which might be helpful to improve the bioavailability of active constituents of ashwAGandha extract that might provide better therapeutic response against inflammatory diseases, immunological disorders, arthritis, stress, cancer, diabetes, sexual disorders, aging, and other chronic infections.
References
More filters
Book

Indian Medicinal Plants

TL;DR: Indian medicinal plants/, Indian medicinal plants /, مرکز فناوری اطلاعات و اصاع رسانی, کδاوρزی
Journal Article

Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.

TL;DR: Preliminary studies have found various constituents of ashwagandha exhibit a variety of therapeutic effects with little or no associated toxicity, indicating this herb should be studied more extensively to confirm these results and reveal other potential therapeutic effects.
Journal ArticleDOI

Steroidal lactones from Withania somnifera, an ancient plant for novel medicine.

TL;DR: An overview of the chemical structures of triterpenoid components and their biological activity is presented, focusing on two novel activities, tumor inhibition and antiangiogenic properties of withaferin A and the effects of withanolide A on Alzheimer's disease.
Journal ArticleDOI

Alzheimer's disease pathogenesis and therapeutic interventions

TL;DR: Inhibition of secretase activity and blocking the formation of beta-amyloid oligomers and fibrils which may inhibit fibrilization and fibilization-dependent neurotoxicity are the most promising therapeutic strategy against the accumulation of Beta-AMyloid fibrILS associated with AD.
Related Papers (5)